Annual EBITDA
-$380.21M$6.06M-1.62%
Summary
- Current Value
- As of today, RLAY annual EBITDA is -$380.21M, down -1.62% on
- Historical Performance
- RLAY annual EBITDA is down -70.44% over the past 3 years, and down -368.22% over the past 5 years
- All-Time High Comparison
- RLAY annual EBITDA is currently -696.50% below its historical high of -$47.74M set on
- 3-Year Low Comparison
- RLAY annual EBITDA is at its 3-year low
- Sector Comparison
- RLAY annual EBITDA is higher than 2.88% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$380.21M | -1.6% | -70.4% | -368.2% | -696.5% | |
| Quarterly EBITDA | -$79.64M | +16.2% | +2.4% | -123.1% | -406.1% | |
| TTM EBITDA | -$322.79M | +17.1% | -11.1% | -185.3% | -1951.4% | |
| Price | $8.05 | +66.6% | -48.4% | -80.2% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $10.01M | -60.8% | +230.4% | +100.0% | +100.0% | |
| Annual EPS | -$2.36 | +15.3% | +38.2% | -182.1% | -335.5% | |
| Annual EBIT | -$385.67M | -1.6% | -69.9% | -358.9% | -673.1% | |
| Annual Net Income | -$337.71M | +1.3% | +7.2% | -348.4% | -592.2% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$306.82M | N/A | -23.9% |
| 5Y | -$52.25M | N/A | -627.7% |
| All | -$47.74M | -696.5% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$380.21M | at low | |
| 5Y | -$380.21M | at low | |
| All | -$380.21M | at low |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$380.21M | -1.6% | |
| -$374.15M | -21.9% | |
| -$306.82M | -37.5% | |
| -$223.08M | -327.0% |
| Year | Value | Change |
|---|---|---|
| -$52.25M | +35.7% | |
| -$81.20M | -70.1% | |
| -$47.74M | - |
FAQ
What is the current annual EBITDA of RLAY?
As of today, RLAY annual EBITDA is -$380.21M
What is 1-year change in RLAY annual EBITDA?
RLAY annual EBITDA is down -1.62% year-over-year
What is 3-year change in RLAY annual EBITDA?
RLAY annual EBITDA is down -70.44% over the past 3 years
How far is RLAY annual EBITDA from its all-time high?
RLAY annual EBITDA is currently -696.50% below its historical high of -$47.74M set on December 31, 2018
How does RLAY annual EBITDA rank versus sector peers?
RLAY annual EBITDA is higher than 2.88% of companies in Healthcare sector
When is RLAY next annual earnings release?
The next annual earnings release for RLAY is on
Quarterly EBITDA
-$79.64M$3.80M-5.01%
Summary
- Current Value
- As of today, RLAY quarterly EBITDA is -$79.64M, down -5.01% on
- Historical Performance
- RLAY quarterly EBITDA is up +16.17% year-over-year, and up +2.39% over the past 3 years
- All-Time High Comparison
- RLAY quarterly EBITDA is currently -321.85% below its historical high of $35.90M set on
- 3-Year Low Comparison
- RLAY quarterly EBITDA is +28.10% above its 3-year low of -$110.76M reached on
- Sector Comparison
- RLAY quarterly EBITDA is higher than 4.25% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$79.64M | -5.0% | +16.2% | +2.4% | -123.1% | |
| Annual EBITDA | -$380.21M | – | -1.6% | -70.4% | -368.2% | |
| TTM EBITDA | -$322.79M | +4.5% | +17.1% | -11.1% | -185.3% | |
| Price | $8.05 | +18.7% | +66.6% | -48.4% | -80.2% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $0.00 | -100.0% | 0.0% | -100.0% | 0.0% | |
| Quarterly EPS | -$0.43 | -4.7% | +31.6% | +43.3% | +81.9% | |
| Quarterly EBIT | -$80.39M | -4.6% | +16.6% | +2.7% | -119.6% | |
| Quarterly Net Income | -$74.15M | -5.4% | +15.8% | +11.9% | -105.5% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$75.85M | -5.0% | |
| 3Y | -$73.41M | -8.5% | |
| 5Y | $35.90M | N/A | -321.9% |
| All | $35.90M | -321.9% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$83.66M | +4.8% | |
| 3Y | -$110.76M | +28.1% | |
| 5Y | -$110.76M | +28.1% | |
| All | -$110.76M | +28.1% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of RLAY?
As of today, RLAY quarterly EBITDA is -$79.64M
What is RLAY quarterly EBITDA most recent change?
RLAY quarterly EBITDA was down -5.01% on September 30, 2025
What is 1-year change in RLAY quarterly EBITDA?
RLAY quarterly EBITDA is up +16.17% year-over-year
How far is RLAY quarterly EBITDA from its all-time high?
RLAY quarterly EBITDA is currently -321.85% below its historical high of $35.90M set on December 31, 2020
How does RLAY quarterly EBITDA rank versus sector peers?
RLAY quarterly EBITDA is higher than 4.25% of companies in Healthcare sector
When is RLAY next earnings release?
The next earnings release for RLAY is on
TTM EBITDA
-$322.79M$15.36M+4.54%
Summary
- Current Value
- As of today, RLAY TTM EBITDA is -$322.79M, up +4.54% on
- Historical Performance
- RLAY TTM EBITDA is up +17.12% year-over-year, and down -11.14% over the past 3 years
- All-Time High Comparison
- RLAY TTM EBITDA is currently -1951.44% below its historical high of -$15.74M set on
- 3-Year Low Comparison
- RLAY TTM EBITDA is +17.12% above its 3-year low of -$389.45M reached on
- Sector Comparison
- RLAY TTM EBITDA is higher than 3.43% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$322.79M | +4.5% | +17.1% | -11.1% | -185.3% | |
| Annual EBITDA | -$380.21M | – | -1.6% | -70.4% | -368.2% | |
| Quarterly EBITDA | -$79.64M | -5.0% | +16.2% | +2.4% | -123.1% | |
| Price | $8.05 | +18.7% | +66.6% | -48.4% | -80.2% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $8.36M | 0.0% | -16.5% | +393.0% | +100.0% | |
| TTM EPS | -$1.75 | +10.2% | +33.0% | +34.3% | +45.7% | |
| TTM EBIT | -$327.09M | +4.7% | +17.2% | -11.1% | -180.5% | |
| TTM Net Income | -$297.59M | +4.5% | +13.8% | -2.5% | -166.7% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$322.79M | at high | |
| 3Y | -$306.82M | N/A | -5.2% |
| 5Y | -$52.25M | N/A | -517.8% |
| All | -$15.74M | -1951.4% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$380.21M | N/A | +15.1% |
| 3Y | -$389.45M | +17.1% | |
| 5Y | -$389.45M | +17.1% | |
| All | -$389.45M | +17.1% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of RLAY?
As of today, RLAY TTM EBITDA is -$322.79M
What is RLAY TTM EBITDA most recent change?
RLAY TTM EBITDA was up +4.54% on September 30, 2025
What is 1-year change in RLAY TTM EBITDA?
RLAY TTM EBITDA is up +17.12% year-over-year
How far is RLAY TTM EBITDA from its all-time high?
RLAY TTM EBITDA is currently -1951.44% below its historical high of -$15.74M set on March 31, 2019
How does RLAY TTM EBITDA rank versus sector peers?
RLAY TTM EBITDA is higher than 3.43% of companies in Healthcare sector
When is RLAY next earnings release?
The next earnings release for RLAY is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- RLAY Official Website www.relaytx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1812364/000119312525269601/0001193125-25-269601-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1812364/000095017025027756/0000950170-25-027756-index.htm
- RLAY Profile on Yahoo Finance finance.yahoo.com/quote/RLAY
- RLAY Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rlay